Fjarde Ap Fonden Viatris Inc Transaction History
Fjarde Ap Fonden
- $10.8 Billion
- Q2 2025
A detailed history of Fjarde Ap Fonden transactions in Viatris Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 43 shares of VTRS stock, worth $438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 156,990
99.97%
Holding current value
$438
Previous $1.37 Million
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,128Shares Held
986MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$944 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$803 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$676 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$563 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...